Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study

Week 2 remission with VDZ is a predictor of week 54 remission in patients with UC. Week 2 may be used as an evaluation point for UC treatment decisions. (Japanese Registry of Clinical Trials: jRCT-1080225363).

Authors

Institutions

Publication Details

Journal
Intestinal Research
Published
2025-07-14
DOI
https://doi.org/10.5217/ir.2025.00047
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study

Sakiko Hiraoka, Keiichi Tominaga, Reiko Kunisaki, Toshifumi Hibi∥ et al.
1 links
Intestinal Research
Inflammatory Bowel Disease
article

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study

Sakiko Hiraoka, Keiichi Tominaga, Reiko Kunisaki, Toshifumi Hibi∥, Mary Cavaliere, Tadakazu Hisamatsu, Noritaka Takatsu, Toshimitsu Fujii, Minoru Matsuura, Taku Kobayashi, Satoshi Motoya, Hiroshi Yasuda, Nobuaki Kuno, Tomoyoshi Shibuya, Atsuo Maemoto, Kaoru Yokoyama, Ken Takeuchi, Masaaki Shimada, Kaori Ishiguro, Toshiyuki Tahara, J. Fernández
article en

Abstract

Week 2 remission with VDZ is a predictor of week 54 remission in patients with UC. Week 2 may be used as an evaluation point for UC treatment decisions. (Japanese Registry of Clinical Trials: jRCT-1080225363).

Intestinal Research
St. Marianna University School of Medicine (JP), Kyorin University (JP), Yokohama City University Medical Center (JP), Fukuoka University (JP), Juntendo University (JP), Sapporo Higashi Tokushukai Hospital (JP), Fukuoka University Hospital (JP), Okayama University Hospital (JP), Sapporo Kosei General Hospital (JP), Saiseikai Utsunomiya hospital (JP), Nagoya Medical Center (JP), Kitasato Institute Hospital (JP), Kashiwa Municipal Hospital (JP), Takeda (Japan) (JP), Kitasato University (JP), Dokkyo Medical University (JP), Yokohama City University (JP)
Good health and well-being
Openalex Percentile: Top 80%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.